Zepbound, known generically as tirzepatide, is a once-weekly injectable medication approved by the FDA to help adults manage chronic weight issues
Red blood cell counts rising after beginning B12 injections is a clear sign that the treatment is effective
Since its introduction, this formulation has set industry standards for quality and efficacy in B12 supplementation, particularly in treating deficiency states and supporting overall wellness
Issues such as small sample sizes, lack of control groups, and short follow-up periods further weaken the validity of these studies
BPC-157 + TB-500
(2) F M Ng, W J Jiang, R Gianello, S Pitt, and P Roupas (2000)